𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Study of the Pharmacokinetic Profile of Low-Dose Hepatitis B Immune Globulin in Long-Term Liver Transplant Recipients for Chronic Hepatitis B Infection

✍ Scribed by Nilufar Partovi; Michelle W. Guy; Mary H. H. Ensom; Michael A. Noble; Eric M. Yoshida

Book ID
114423355
Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
57 KB
Volume
1
Category
Article
ISSN
1600-6135

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Liver transplantation for chronic hepati
Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin
✍ Yoshida, Eric M. ;Erb, Siegfried R. ;Partovi, Nilufar ;Scudamore, Charles H. ;Ch 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 71 KB 👁 1 views

Current protocols for prophylaxis against allograft reinfection after liver transplantation for chronic hepatitis B virus (HBV) infection include the administration of large doses of hepatitis B immune globulin (HBIG), with considerable associated economic costs. Monotherapeutic prophylaxis with lam

A randomized, open-label study to evalua
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients
✍ Gary L. Davis; David R. Nelson; Norah Terrault; Timothy L. Pruett; Thomas D. Sch 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

## Collaborative Antiviral Study Group Chronic hepatitis C is the most common indication for liver transplantation, but viral recurrence is universal and progressive graft injury occurs in most recipients. Our aim was to assess the safety, pharmacokinetics (PK), and antiviral effects of high doses